Clinical trial
Double-blind Randomised Controlled Trial for Treatment of Gastro-Oesophageal Reflux Disease; LINX Management System vs. Fundoplication (GOLF)
NCT07093359 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-blind Randomised Controlled Trial for Treatment of Gastro-Oesophageal Reflux Disease; LINX Management System vs. Fundoplication (GOLF)
- Lead sponsor
- University of Oxford
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- March 6, 2025
- Completion date
- July 31, 2029
- Enrollment
- 460 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
gastro-oesophageal reflux disease